Literature DB >> 28695522

Purification of Recombinant Human PARP-3.

Jean-Christophe Amé1, Barbara Camuzeaux2, Françoise Dantzer2, Valérie Schreiber2.   

Abstract

The purification of poly(ADP-ribose) polymerase-3 (PARP-3) from overexpressing cells (Sf9 insect cells, Escherichia coli) has been updated to a fast and reproducible two chromatographic steps protocol. After cell lysis, PARP-3 protein from the crude extract is affinity purified on a 3-aminobenzamide Sepharose™ chromatographic step. The last contaminants and the 3-methoxybenzamide used to elute PARP-3 from the previous affinity column are removed on the high-performance strong cations exchanger MonoQ™ matrix. This step allows also the concentration of the protein. The columns connected to an ÅKTA™ purifier system allow the purification of the protein in 3 days with a high-yield recovery. As described in the protocol, more than 3 mg of pure and active human PARP-3 can be obtained from 1.5 L of E. coli culture.

Entities:  

Keywords:  Affinity chromatography; PARP inhibitors; PARP-3 purification; Poly(ADP-ribose) polymerase

Mesh:

Substances:

Year:  2017        PMID: 28695522     DOI: 10.1007/978-1-4939-6993-7_24

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  1 in total

1.  PARP3 supervises G9a-mediated repression of adhesion and hypoxia-responsive genes in glioblastoma cells.

Authors:  Leonel Nguekeu-Zebaze; Najat Hanini; Aurélia Noll; Nadège Wadier; Jean-Christophe Amé; Lisa Roegel; Françoise Dantzer
Journal:  Sci Rep       Date:  2022-09-15       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.